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Abstract
The phosphatidylinositol glycan anchor biosynthesis class S protein (PIGS) gene 
has recently been implicated in a novel congenital disorder of glycosylation re-
sulting in autosomal recessive inherited glycosylphosphatidylinositol-anchored 
protein (GPI-AP) deficiency. Previous studies described seven patients with bial-
lelic variants in the PIGS gene, of whom two presented with fetal akinesia and 
five with global developmental delay and epileptic developmental encephalopathy. 
We present the molecular and clinical characteristics of six additional individu-
als from five families with unreported variants in PIGS. All individuals presented 
with hypotonia, severe global developmental delay, microcephaly, intractable early 
infantile epilepsy, and structural brain abnormalities. Additional findings include 
vision impairment, hearing loss, renal malformation, and hypotonic facial appear-
ances with minor dysmorphic features but without a distinctive facial gestalt. Four 
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1 |  INTRODUCTION
Congenital disorders of glycosylation (CDGs) are a rapidly 
growing heterogeneous group of genetic conditions. Inherited 
glycosylphosphatidylinositol-anchored protein (GPI-AP) 
deficiencies (IGDs) are a subset of CDGs that account for 
0.15% of all neurodevelopmental disorders.1 In many cases, 
IGDs result from the failure of the GPI anchor to regulate 
APs on the external cell surface. This has consequences for 
early human neurogenesis and neurodevelopment.2–5 To date, 
17 known IGDs lead to a wide range of symptoms, including 
variable intellectual disabilities and developmental impair-
ment, seizures, hypotonia, weakness, ataxia, congenital mal-
formations, and dysmorphic facial features. There are more 
than 150 human GPI-APs, which often play a role in synaptic 
function, development of the central nervous system (CNS), 
and plasticity; defects in several of these proteins have been 
implicated in various neurological disorders.2
Developmental and epileptic encephalopathies include a 
range of severe epilepsies in which intractable seizures are 
accompanied by impairment of motor and cognitive func-
tions.6 Recently, many cases of IGD have been found among 
individuals with intellectual disability and intractable sei-
zures. Early infantile epileptic encephalopathy-55 (EIEE; 
Mendelian Inheritance in Man [MIM] #617599), a severe 
form of epilepsy with frequent tonic seizures or spasms be-
ginning in infancy, and developmental delay or regression, 
has been linked to several genes important for GPI biosyn-
thesis and attachment. For example, PIGB, PIGQ, PIGP, and 
PGAP1 have all been linked to novel autosomal recessive 
IGDs7–9; PIGA is an X-linked recessive disorder.10
Phosphatidylinositol glycan class S (PIGS; MIM #610271) 
encodes a GPI-AP, specifically a subunit of the GPI trans-
amidase complex that catalyzes the attachment of preformed 
GPI to proteins containing a C-terminal GPI attachment 
signal. Biallelic variants in PIGS have recently been impli-
cated in human diseases, with the observation of seven indi-
viduals affected with EIEE.11,12 Phenotypes included severe 
global developmental delay, seizures, hypotonia, weakness, 
ataxia, and dysmorphic facial features, but also multiple joint 
contractures (consistent with fetal akinesia) in two fetuses. 
All seven individuals showed a GPI-AP deficiency profile. 
Notably, one individual showed a reduction in seizure fre-
quency with pyridoxine (100 mg per day).
We describe six individuals (from five unrelated families) 
carrying biallelic variants in PIGS and presenting with hypo-
tonia, severe global developmental delay, infantile onset (in-
tractable) seizures, and different CNS anomalies identified 
on brain imaging. Two patients in this cohort are responsive 
to pyridoxine. This study provides additional evidence for 
PIGS as an emerging gene associated with autosomal reces-
sive EIEE and describe the clinical characteristics, prognosis, 
and treatment outcomes, to improve patient care.
2 | MATERIALS AND METHODS
2.1 | Human participants
The study was approved by the ethics institutional review board 
of University College London and additional local ethics com-
mittees of the participating centers (see also Supplementary 
Data S1). Informed consent was obtained from all families.
2.2 | Exome and Sanger sequencing
Biallelic variants in the PIGS gene were identified by exome 
sequencing (ES) as previously described.13,14 All variants are 
listed using canonical transcript NM_033198.4.
individuals died due to neurologic complications. GPI anchoring studies performed 
on one individual revealed a significant decrease in GPI-APs. We confirm that 
biallelic variants in PIGS cause vitamin pyridoxine-responsive epilepsy due to in-
herited GPI deficiency and expand the genotype and phenotype of PIGS-related 
disorder. Further delineation of the molecular spectrum of PIGS-related disorders 
would improve management, help develop treatments, and encourage the expan-
sion of diagnostic genetic testing to include this gene as a potential cause of neu-
rodevelopmental disorders and epilepsy.
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2.3 | Computational and in vitro 
splice analysis
Computational analysis of the c.174G>C variant was per-
formed as previously described.15 To assess the predicted 
splicing impact of the c.174G>C (p.Gln58His) variant in 
Patients 1 and 2, an in vitro splicing assay was performed 
with minor modifications.16
2.4 | Flow cytometry analyses
Fluorescence-activated cell sorting analysis to assess for re-
duction in cell-surface expression of GPI-APs was done for 
Patient 6 and performed as previously described.15
3 | RESULTS
3.1 | Clinical findings
We identified six novel patients from five families with bi-
allelic variants in the PIGS gene found by trio ES. Parental 
consanguinity was reported in four of the five families, 
all of whom had homozygous variants in PIGS. The clini-
cal features of the affected individuals are summarized in 
Table S1 and are described further in Supplementary Data 
S1. All individuals presented with severe global develop-
mental delay, intractable early infantile onset seizures, and 
absent speech. Patients 2, 3, and 5 died from complica-
tions of recurrent respiratory infections. Intractable sei-
zures requiring multiple antiepileptic drugs (AEDs) were 
noted in all patients. The electroencephalographic (EEG) 
features in our cohort were variable, influenced by the age 
of the patients and the effect of the specific variant; how-
ever, all subjects showed EEG recording indicative of a 
severe developmental epileptic encephalopathy, that is, 
pseudohypsarrhythmia with runs of high amplitude and 
slow waves predominant over posterior regions associated 
with multifocal epileptic abnormalities within a diffusely 
slowed high amplitude during wakefulness and sleep or 
within a burst-suppression pattern. All of the individuals 
in this cohort had abnormal findings on brain magnetic 
resonance imaging, including atrophy of the frontal and 
anterior temporal lobes, with or without generalized brain 
atrophy. Frontal atrophy led to the development of bilateral 
subdural hygromas in one patient (Patient 5). We noted hy-
poplasia of the pons in four patients. One individual with 
severe pontine hypoplasia had large thalami and massa 
intermedia. All six affected individuals had microcephaly 
(−3 SD). Behavioral anomalies in two siblings (Patients 4 
and 5) included autistic features and excessive laughing/
crying. Other variable features include renal malformation 
(1/6, 17%), visual impairment (3/6, 50%), severe hearing 
loss (2/6, 33%), and acquired arthrogryposis (2/6, 33%). 
Facial dysmorphism was observed in most of the affected 
individuals (Figure 1B), mainly consisting of coarse fea-
tures such as thick arched eyebrows, almond-shaped pal-
pebral fissures, depressed nasal bridge, and deep philtrum. 
Brachytelephalangy was also observed in three subjects 
(Patients 1–3), although in one of them (Patient 1) there 
was no evident epiphyseal or metaphyseal abnormality 
upon skeletal survey. Alkaline phosphatase levels (normal 
value = 0–281 U/L) were normal in Patient 2 (206 U/L) 
and mildly elevated in Patient 4 (445 U/L). This finding 
was not available for other affected individuals.
Although seizure management with AEDs is challenging, 
Patients 1 and 6 improved with pyridoxine (15 mg/kg/day) 
and folinic acid (1 mg/kg/day). Patient 1 reported decrease in 
seizure frequency, and Patient 6 reported improved develop-
mental progress.
3.2 | Genetic findings
ES in the probands of Families 1 and 2 revealed a novel 
homozygous variant in exon 2 of PIGS, c.174G>C 
(p.Gln58His), predicted to affect RNA splicing. The vari-
ant segregated with the disease in both families (Figure 1A) 
and was located within a 14-Mb region of homozygosity. 
The variant was absent in publicly available population data-
bases, including gnomAD, Exome Sequencing Project, GME 
Variome, and Iranome, as well as in more than 14,000 in-
house exomes. In Family 3, a novel homozygous missense 
variant c.1070G>A (p.Gly357Asp) within a 10-Mb block of 
homozygosity was detected. The variant occurs at a highly 
conserved amino acid residue (Figure 1E), has a Combined 
Annotation Dependent Depletion score of 27 and Genomic 
Evolutionary Rate Profiling (GERP) score of 5.49, and seg-
regated with the disease in the family. A novel segregating 
homozygous missense variant c.986C>G, (p.Pro329Arg), al-
tering a highly conserved amino acid (Figure 1E), was identi-
fied for Family 4 (GERP score = 5.37). Both p.Gly357Asp 
and p.Pro329Arg are predicted to have a deleterious impact 
on the resulting PIGS protein, based on in silico predictions 
(Table S2).
In Family 5, Patient 6 has two variants. One variant is a 
paternally inherited in-frame insertion of eight amino acids 
in a nonrepeat region, as c.1141_1164dup24 (p.Asp381_
Val388dup) in exon 10. This variant has been previously 
reported in the literature in a male of Chinese descent with 
PIGS-related disorder and seen in gnomAD in a heterozy-
gous carrier state in five individuals of East Asian ethnic-
ity. The second variant is a maternally inherited nonsense 
variant c.734G>A (p.Trp245*) in exon 7. This variant has 
been seen in gnomAD but only in the heterozygous carrier 
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state in one individual of African ethnicity. Table S2 shows 
the allele frequency and American College of Medical 
Genetics and Genomics criteria-based assessment of these 
variants.
3.3 | Splicing analysis
Computational splice analysis of the c.174G>C variant pre-
dicted two possible effects that prompted RNA studies: (1) a 
decrease in the splice donor scores between 12.6% and 43.3% 
and (2) the abolishment of an exonic splicing enhancer motif 
(Figure S2). In vitro RNA analysis of the wild-type c.174G 
disclosed a 508-bp amplicon including exons 2 and 3, as 
well as a 369-bp amplicon with only exon 3 (Figure 1F,G). 
This likely reflects alternative splicing (NM_033198.4/
ENST00000308360.8 and ENST00000395346.6). The am-
plicon with the homozygous c.174G>C variant revealed 
only exon 3 (369 bp), indicating a skipping of exon 2 (Figure 
1F,G) that was Sanger sequence confirmed (Figure 1H). This 
out-of-frame deletion of exon 2 (r.35_174del) would result in 
a premature stop codon (p.Glu12Alafs*31).
3.4 | Flow cytometric analysis
Individual 6 had significantly lower levels of CD16 and fluo-
rescent aerolysin (FLAER) in granulocytes, the most sensitive 
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markers of inherited GPI deficiency (Figure 2). There was 
no decrease for CD55 and CD59 in granulocytes, but these 
are less sensitive markers of inherited GPI deficiency. There 
was also low CD14 in monocytes and low FLAER in lym-
phocytes (Figure S3). This is consistent with the previously 
reported case series that showed biallelic variants in PIGS 
lead to reduced amounts of GPI-AP at the cell surface.15,16 
Due to the country of origin of the two patients still alive and 
the limited clinical facilities, we could not replicate the flow 
cytometric analysis in additional individuals.
4 | DISCUSSION
Our study expands the phenotypic and genotypic spectrum of 
PIGS variants, which have been previously associated with 
profound neurodevelopmental impairment, EIEE, and pre-
mature death. We expand the known population of seven in-
dividuals with biallelic pathogenic variants in PIGS reported 
so far by adding five novel patients. We report five variants, 
four of which were previously unreported; namely, one trun-
cating, one in-frame duplication, and three missense variants. 
According to gnomAD constraint scores, PIGS is intolerant 
toward both missense variants (Z = .7801) and biallelic loss 
of function variants (probability of being loss-of-function in-
tolerant = 0, pREC = .9943).
All patients had hypotonia, microcephaly, global devel-
opmental delay, absent speech, and infantile onset epilepsy. 
Brachytelephalangy was also observed in three patients. 
Although first reported in PIGV-related disorders,17 it is not 
present in all GPI deficiencies.11 We also identified neuroim-
aging findings in our patients, consistent with previously pub-
lished studies that described cerebellar and diffuse cortical 
atrophy in individuals carrying biallelic PIGS variants.11,12 In 
this cohort, vision impairment, hearing loss, and behavioral 
abnormalities were also commonly observed. Taken together, 
biallelic (gene-disruptive) variants in PIGS are associated 
with an early infantile encephalopathy refractory to standard 
AEDs co-occurring with global developmental delay, severe 
hypotonia, and visual and hearing impairment.
Elevated alkaline phosphatase levels have been observed 
in other disorders of GPI anchor synthesis.7 In our cohort, 
only one of two tested patients showed mildly elevated al-
kaline phosphatase levels, supporting the evidence that in-
creased alkaline phosphatase levels are not observed in all 
GPI deficiencies.11
GPI-AP function is also implicated in vitamin B6 and fo-
late transport, nucleotide metabolism, and lipid homeostasis. 
B6-dependent enzymes are involved in the metabolism of 
amino acids, neurotransmitters, molybdenum cofactor, and 
sphingolipids.18 Two of our patients were treated with pyr-
idoxine and folinic acid, with some benefit in seizure con-
trol even before the genetic analysis; moreover, we could not 
measure the cerebrospinal fluid pyridoxal-5-phosphate levels 
primarily due to the limited testing ability of their referring 
hospitals. Although anecdotal, previous studies have also 
shown the effects of pyridoxine in other IGDs.19 Pyridoxine 
has been shown effective in various GPI deficiency disor-
ders, although there is no clear evidence describing the effect 
of folinic acid. The ketogenic diet has also been previously 
reported to improve outcome in cases of PIGA deficiency 
and may be a consideration for individuals with PIGS-related 
disorder.20
This study further reviewed the clinical features of PIGS-
related disorders. Distinguishing PIGS-related disorders 
from other pediatric neurological syndromes will rely on 
F I G U R E  1  Clinicogenetic, radiological, and molecular findings of individuals in our cohort. (A) Pedigrees and segregation results (+ 
represents the variant) of the five families carrying biallelic PIGS variants. (B) Patients 1–5 show coarse facial features, including arched eyebrows, 
almond-shaped palpebral fissures, depressed nasal bridge, deep philtrum, and pointed chin. (C) A schematic representation of the PIGS protein 
showing the position of all PIGS variants identified, with previously reported variants in red. (D) Magnetic resonance imaging findings of (i–iii) 
Patient 6 at 5 weeks. Sagittal T-weighted image at the midline (i) shows small pons (arrow), early superior cerebellar vermian atrophy (arrowhead), 
and a large massa intermedia (star). Parasagittal T1-weighted image (ii) shows underdeveloped and undersulcated frontal lobes (arrow). Compare 
the sulcation in the anterior aspects with the posterior cerebral hemisphere. Axial T2-weighted image (iii) shows underopercularization due to 
underdevelopment of the frontal and anterior temporal lobes and large thalami (star). (iv, v) Patient 4 at 5 years. Axial T2-weighted images at the 
supratentorial (iv) and infratentorial (v) levels show generalized brain atrophy and delayed maturation of myelin. Note again the worse atrophy 
anteriorly in the frontotemporal regions. (vi) Patient 5 at 5 months. Axial T2-weighted image shows atrophy-related bilateral subdural hygromas 
(arrow). (vii) Patient 1 at 3.5 months. Axial T2-weighted image shows underopercularization bilaterally secondary to frontotemporal atrophy. Frontal 
dysgyria is also noted. (viii) Patient 2 at 34 weeks. Sagittal T1-weighted image shows microcephaly, with greater volume reduction in the frontal 
lobe, as well as early superior cerebellar vermian atrophy (arrow). (ix) Patient 3 at 14 months. Sagittal T1-weighted image shows a small pons and 
globally reduced cerebral white matter volume (worse anteriorly) associated with hypoplasia of the corpus callosum. (E) Interspecies alignment 
performed with Clustal Omega shows the complete conservation down to invertebrates of the amino acid residues affected by the substitutions. (F) 
RNA analysis of the PIGS c.174G>C variant. Gel electrophoresis of the reverse transcriptase polymerase chain reaction (PCR) wild-type (WT), 
mutant (Mut) c.174G>C variant, and empty pSPL3 vector amplicons. Transfection negative and PCR negative controls performed as expected. (G) 
Overview of the splicing of the wild-type (upper panel), patient (middle panel), and empty vector (lower panel) splicing. Note that although exon 1 
was cloned into the vector, it was not spliced to exon A and exon 2, as it lacks a splice acceptor site. (H) Visualization of the exon junction sequence 
of the wild-type (upper panel), patient (middle panel), and empty vector (lower panel)
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the combination of physical examination findings and iden-
tifying the phenotypic features resulting from disruption of 
PIGS. These include intractable epilepsy, severe develop-
mental delay, hypotonia, and coarse faces. Our data further 
highlight the importance of including the screening of the 
PIGS gene in the case of infantile epilepsy and may serve 
for improved interpretation of new PIGS variants with the 
help of biochemical findings and flow cytometry analysis. 
Finally, PIGS is not found on most clinically utilized epilepsy 
gene panels, suggesting that it may be a more frequent cause 
of early infantile epilepsy than reported. As epilepsy genetic 
testing expands and ES becomes more available, more pa-
tients will likely be identified in the future.
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